TALEVICH JAMES R 4

4 · BIOLASE, INC · Filed May 14, 2018

Form 4

Period: 2018-05-11

Director

Transactions

Exercise/Conversion
Common Stock
2018-05-11+7,394→ 20,374 total
Exercise/Conversion
Restricted Stock Unit
2018-05-11−7,394→ 0 total
→ Common Stock (7,394 underlying)
Award
Restricted Stock Unit
2018-05-14+18,208→ 18,208 total
→ Common Stock (18,208 underlying)
Award
Restricted Stock Unit
2018-05-14+91,379→ 109,587 total
→ Common Stock (91,379 underlying)

Footnotes (4)

[F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
[F2]On May 10, 2017, the reporting person was granted 35,211 restricted stock units, which vested on May 11, 2018. On May 10, 2018, the Company issued a press release announcing that, at the Annual Meeting, the Company's stockholders approved a proposal to amend the Company's Restated Certificate of Incorporation to effect a reverse stock split of Company common stock at a ratio of not less than 1-for-5 and not more than 1-for-15, with the final ratio to be determined by the Board. Immediately after the Annual Meeting, the Board approved the reverse stock split at a ratio of one post-split share for every five pre-split shares.
[F3]The restricted stock units vest as follows: (i) two-fifths of the restricted stock units vest on December 31, 2018, and (ii) three-fifths of the restricted stock units vest on December 31, 2019.
[F4]The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award.

Documents

1 file